GLD-2
This article includes a improve this article by introducing more precise citations. (March 2016) ) |
TENT2 | |||
---|---|---|---|
Gene ontology | |||
Molecular function | |||
Cellular component | |||
Biological process | |||
Sources:Amigo / QuickGO |
View/Edit Human | View/Edit Mouse |
GLD-2 (which stands for Germ Line Development 2) is a cytoplasmic poly(A) polymerase (cytoPAPs) which adds successive AMP monomers to the 3’ end of specific RNAs, forming a poly(A) tail, which is a process known as polyadenylation.
For RNA specificity, GLD-2 associates with an RNA-binding protein, typically a GLD-3, to form a
This family of cytoplasmic PAPs has been described in several different species including
Localization
GLD-2 is a common and abundant, but yet quite unknown protein that has already been found in each of the
In human beings it is mostly expressed in the brain and within it, in the cerebellum, hippocampus and medulla. We can also find them in some other source tissues are the fibroblast, HeLa cell, MCF-7 cell, melanoma cell line and
In Escherichia Coli, this enzymatic protein can be found in the cell membrane and in the cytosol, whereas in Drosophila melanogaster, it predominates in the brain's nucleus and cytoplasm, oocyte, ovary and testis’ cells. Finally, in the Arabidopsis thaliana, it is located in the flower's nucleus, root, stem and leaf cells.
Related functions
GLD-2 primarily stabilizes mRNAs that are translationally repressed as well as it strongly promotes bulk polyadenylation. Surprisingly, those functions seem to have little impact on dynamizing efficient target mRNA translation, as it is an efficient Poly(A) Polymerase which helps developing polyadenylation activity. This activity is stimulated by its interaction with a putative RNA-binding protein: GLD-3. It is proposed by some studies that GLD-3 stimulates GLD-2 by recruiting it to the RNA. If so, then bringing GLD-2 to the RNA by other means also should stimulate its activity.
Molecular function
ATP binding
GLD-2, as a poly(A) polymerase (PAP) acts incorporating ATP at the 3' end of mRNAs in a template-independent manner.
Enzymatic activity: Polynucleotide adenylyltransferase activity
It has been discovered that this protein has a catalytic activity, in other words, it has the ability to increase the speed of chemical reactions which would not occur so fast. It is known to
ATP + RNA(n) ⇄ diphosphate + RNA(n+1)
Depending on the surroundings the optimal pH varies from 8 in the cytoplasm to 8.3 in the nucleus.
Biological process
Hematopoietic progenitor cell differentiation
The GLD-2 protein together with 136 proteins more, is involved in the molecular process of
mRNA processing by RNA polyadenylation
The polyadenylation activity of GLD-2, as we previously mentioned, is stimulated by physical interaction with an RNA binding protein, GLD-3. To test whether GLD-3 might stimulate GLD-2 by recruiting it to RNA, some studies tethered C. elegans GLD-2 to mRNAs in Xenopus
Furthermore, GLD-2 activity is also important to maintain or up-regulate the abundance of many mRNAs, as the cytoplasmic polyadenylation has an essential role in activating maternal
The Xenopus enzyme, which exists in two closely related forms, polyadenylates RNAs to which it is tethered and enhances their translation. Likewise, it interacts with cytoplasmic polyadenylation factors, including
In addition, the formation of long-term memory is believed to lack translational control of localized mRNAs. In mammals, dendrite mRNAs are kept in a repressed state and are activated upon repetitive stimulation. Several regulatory proteins required for translational control in early development are thought to be needed for memory formation, suggesting similar molecular mechanisms. In an experiment using Drosophila, it has been detected the enzyme responsible for poly(A) elongation in the brain and it has been demonstrated too that its activity is required specifically for long-term memory. These findings provide strong evidence that cytoplasmic polyadenylation is critical for memory formation, and that GLD2 is the responsible enzyme.
Medical implications
It has also been discovered that GLD2 has medical uses.
For example, such enzyme is overexpressed in patients who suffer from cancer; that's why it can be used as a prognostic factor for early appearance in breast cancer patients. Moreover, PAP activity is used to measure the effect of anticancer drugs as etoposide and cordycepin in two carcinoma cell lines: HeLa, which is the human epithelioid cervix carcinoma, and MCF-7 (human breast cancer). However, in spite its utilities it can also be involved in the expression of several common diseases such as:
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000164329 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Further reading
- "UniProtKB - Q6PIY7 (GLD2_HUMAN)". UniProt.
- Nousch M, Yeroslaviz A, Habermann B, Eckmann CR (October 2014). "The cytoplasmic poly(A) polymerases GLD-2 and GLD-4 promote general gene expression via distinct mechanisms". Nucleic Acids Research. 42 (18). Oxford Journals: 11622–33. PMID 25217583.
- "GLD-2". InteractiveFly: GeneBrief.
- Kwak JE, Wang L, Ballantyne S, Kimble J, Wickens M (March 2004). "Mammalian GLD-2 homologs are poly(A) polymerases". Proceedings of the National Academy of Sciences of the United States of America. 101 (13): 4407–12. PMID 15070731.
- Kwak JE, Wickens M (June 2007). "A family of poly(U) polymerases". RNA. 13 (6): 860–7. PMID 17449726.
- Martin G, Möglich A, Keller W, Doublié S (August 2004). "Biochemical and structural insights into substrate binding and catalytic mechanism of mammalian poly(A) polymerase". Journal of Molecular Biology. 341 (4): 911–25. PMID 15328606.
- "PAPD4 » Poly(A) RNA polymerase GLD2 [ EC 2.7.7.19 ]". Nexprot BETA.
- "GO:0002244 » Hematopoietic progenitor cell differentiation". NextProt BETA.
- Nousch M, Yeroslaviz A, Habermann B, Eckmann CR (October 2014). "The cytoplasmic poly(A) polymerases GLD-2 and GLD-4 promote general gene expression via distinct mechanisms". Nucleic Acids Research. 42 (18): 11622–33. PMID 25217583.
- Nakel K, Bonneau F, Eckmann CR, Conti E (July 2015). "Structural basis for the activation of the C. elegans noncanonical cytoplasmic poly(A)-polymerase GLD-2 by GLD-3". Proceedings of the National Academy of Sciences of the United States of America. 112 (28): 8614–9. PMID 26124149.
- "Information on EC 2.7.7.19 - polynucleotide adenylyltransferase". BRENDA Data Base.